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Case report
A 45-year-old woman with a history of  systemic lupus 
erythematosus presented for workup of  a palpable abnor-
mality of  the left breast. The patient identified this abnor-
mality on self-examination three months earlier. In the 
lower inner quadrant of  the left breast, there was report-
edly a lobulated smooth mobile mass. No lymphadenopa-
thy was evident on clinical examination. Since the patient 
recently had a screening mammogram with benign findings 
(Fig. 1), she underwent a breast sonogram. No sonographic 
correlate was found in the area of  the palpable abnormal-
ity. Thus, the patient was followed clinically, and the diag-
nosis of  lupus mastopathy was considered.
Due to persistence of  the palpable abnormality, the pa-
tient underwent a contrast-enhanced breast MRI (Fig. 2). 
In the left lower inner breast, a lobulated irregular mass 
measuring 2.7 x 2.2 cm, hypointense on T1-weighted im-
ages and hyperintense on T2-weighted images, was seen. 
The mass had kinetics demonstrating a rapid rise to peak 
with washout. The mass also had increased circumferential 
signal on STIR images, suggesting possible edema. A sec-
ond mass demonstrating similar kinetics was seen in the 
supra-areolar region. Scattered enhancing nodules were 
incidentally noted in the right breast. 
Excisional biopsy of  the area of  the MRI abnormality 
was performed. On pathology, multifocal angiosarcoma of  
intermediate to high grade was identified. The largest focus 
measured 1.6 cm. Histologic sections showed neoplastic 
blood vessels lined by endothelial cells with marked cyto-
logic atypia as well as frequent associated mitoses. Inter-
mediate- to high-grade areas consisted of  solid growth or 
prominent endothelial tufting with papillary formations as 
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Figure 1. 45-year-old woman with primary breast angiosarcoma. 
Mammogram with left craniocaudal (A) and mediolateral oblique 
(B) views.
well as blood lakes (Fig. 3). Other areas were low-grade and 
seen as anastomosing, thin-walled, vascular channels invad-
ing into and around benign mammary lobules and stroma. 
Fine-needle aspiration of  the right breast nodules revealed 
no malignant foci. The patient was free of  metastatic dis-
ease, as determined by CT of  the abdomen and the pelvis 
and bone scintigraphy. The patient elected to undergo bi-
lateral mastectomy. The mastectomy specimen of  the left 
breast revealed tumor in the lower inner quadrant, measur-
ing 3.5 cm. The resection margins were negative. The right 
mastectomy specimen contained only benign findings. 
Following mastectomy, the patient completed adjuvant 
chemotherapy with doxorubicin. She is three years post 
mastectomy with recurrence-free survival. Due to the high 
risk of  recurrence, she continues to be closely followed with 
serial CT scans of  the chest, abdomen, and pelvis every 6 
months.
Discussion
Angiosarcomas are highly malignant vascular neoplasms. 
They may present as primary tumors, or arise secondary to 
irradiation (postirradiation angiosarcoma) or lymphedema 
(lymphedema-associated cutaneous angiosarcoma), typi-
cally in patients who have undergone treatment for breast 
cancer (2). Secondary angiosarcomas present in older 
women at a mean age of  60 years, compared to two to 
three decades earlier for primary angiosarcomas. Secon-
dary angiosarcomas present with a mean age of  onset of  6 
years after irradiation, with an average tumor size of  7.5 
cm. Multicentricity is seen in up to one-third of  patients 
with secondary disease, and these tumors are typically high 
grade (3). 
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Figure 2. 45-year-old woman with primary breast angiosarcoma. 
MRI. Left sagittal views (A, B) demonstrate a smooth, lobulated, 
hypointense mass on precontrast, T1-weighted images (A); and 
hyperintense on fat-saturated postcontrast images (B). Circumfer-
ential edema surrounds the hyperintense mass on the axial STIR 
image (C). The mass demonstrated rapid rise to peak with washout 
(D, red). 
Figure 3. 45-year-old woman with primary breast angiosarcoma, 
intermediate and high grades. The presence of solid growth pat-
tern, prominent endothelial tufting with papillary projections, and 
blood lakes (not shown) are diagnostic features (Hematoxylin and 
Eosin stain; 200X magnification).
While patients with primary angiosarcoma may present 
as early as their teens and into their 70s, the average age of  
diagnosis is late 30s to early 40s (2, 4, 5, 6). Patients fre-
quently identify an abnormality before the onset of  screen-
ing mammograms; thus, masses are large enough to be 
palpable, with an average diameter of  4.6 to 5.9 cm at di-
agnosis (4, 5). Primary and secondary angiosarcomas usu-
ally present as palpable masses (4, 7) or with fullness, swel-
ling, and irregularity of  the breast (2, 8). Sometimes, there 
is bluish discoloration of  the skin, due to the presence of  
blood vessels. This finding is most evident in primary an-
giosarcoma, as patients with secondary angiosarcoma may 
have postoperative changes and skin thickening from 
chronic lymphedema and radiation. 
The patient described here was premenopausal, had no 
history of  prior radiation therapy or lymphedema, and had 
a single palpable abnormality at initial presentation, consis-
tent with primary (rather than secondary) angiosarcoma. 
The diagnosis of  primary angiosarcoma is particularly 
difficult due to the young patient population it afflicts and 
the nonspecific findings on ultrasound and mammography. 
On ultrasound, angiosarcomas can include a wide spec-
trum of  findings. They may be well-circumscribed or 
poorly marginated. They may be diffuse. They may be hy-
poechoic or of  mixed echogenicity. Angiosarcomas typically 
do not contain angular margins or posterior shadowing, 
which is typical of  breast carcinomas, but do show hyper-
vascularity on color Doppler imaging. 
Mammographically, angiosarcomas, when identified, 
appear most commonly as ill-defined masses, without spicu-
lations or calcifications. The patient described had a screen-
ing mammogram months before identification of  the pal-
pable mass, yet the mammogram revealed benign findings. 
This is not an uncommon occurrence. In a study of  21 
cases by Liberman et al., one-third of  patients had no re-
markable findings on mammography. Angiosarcomas were 
more commonly missed if  of  low histological grade (5). 
Yang et al. found that in a study of  16 breast angiosarco-
mas, 31% of  mammograms were scored as BI-RADS® 2. 
Angiosarcomas may be especially hard to distinguish due to 
dense parenchyma, which is typically seen in these younger 
patients. 
Angiosarcomas are best discriminated from normal 
breast parenchyma via MRI. They are seen as large, lobu-
lar masses with indistinct borders. Low-grade tumors are 
hypointense on T1-weighted images and hyperintense on T2-
weighted images, whereas high-grade angiosarcomas may 
have irregular areas that are hyperintense on T1-weighted 
images, corresponding to hemorrhage or venous lakes. 
Their more aggressive nature is suggested by rapid en-
hancement and washout (type 3 curve) (2). 
On pathology, angiosarcomas can resemble benign vas-
cular lesions such as hemangiomas. In a study by Rosen et 
al., three of  63 patients with angiosarcoma were initially 
misdiagnosed as having hemangioma on biopsy. Angiosar-
comas and hemangiomas are composed of  thin-walled cap-
illaries lined by cytologically bland/low-nuclear-grade en-
dothelial cells. Mitotic figures are rare in well-differentiated 
angiosarcomas and may not be present with limited sam-
pling. However, hemangiomas differ from angiosarcomas in 
that they are usually less than 2 cm, they are well circum-
scribed, and their vascular channels go around ducts and 
lobules rather than invading them. 
Prognosis depends on tumor grade. Previous reports 
have found a five-year disease-free survival of  76% and 
70% for low- and intermediate-grade disease, respectively, 
compared to only 15% for high-grade angiosarcoma (9). 
The median length of  disease-free survival ranges from 
greater than 15 years to 15 months for low- and high-grade 
tumors, respectively. Tumor size and resection margin 
status are also significant prognostic factors (1, 10). 
Breast angiosarcomas rarely metastasize to the regional 
lymph nodes (1, 9, 11) and more commonly undergo he-
matogenous spread to the lung, the liver, and the bones (4, 
9). PET with 18F-FDG can be used for staging, with up-
take seen for tumors in the pleura, heart, and liver. CT is 
frequently used to monitor for recurrence.
Angiosarcomas are usually treated with total mastectomy 
due to their large size, although breast-conserving treat-
ment with axillary lymph-node dissection can be consid-
ered for small, low-grade tumors. There is a high rate of  
systemic recurrence. In one study of  69 breast angiosar-
coma patients, 55% of  patients experienced recurrence 
after 40-months' followup (12). The effect of  adjuvant 
chemotherapy has yet to be examined for breast angiosar-
comas, due to their low prevalence, though retrospective 
studies have failed to show a significant difference in overall 
and recurrence-free survival (12). Studies from primary 
soft-tissue sarcomas have shown increased time to recur-
rence and overall recurrence-free survival with 
doxorubicin-based chemotherapy or epirubicin plus isofos-
famide (13, 14). In this reported case, despite this patient 
having high-grade angiosarcoma, she is recurrence-free 
three years following mastectomy. 
Though rare, primary angiosarcoma should be consid-
ered when a 20- to 50-year-old woman presents with a pal-
pable mass that appears to be growing rapidly. On mam-
mography, calcifications or spiculations that typify breast 
carcinoma may not be present. Ultrasound is frequently 
inconclusive, but hypervascularity is seen with color Dop-
pler imaging. If  the area of  the palpable abnormality is 
visualized on ultrasound, a core biopsy should be per-
formed. If  the biopsy is inconclusive or if  the mass contin-
ues to enlarge, a repeat biopsy and MRI should be 
considered.
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